Nobody Is Talking About the Best Tech Play After Amazon's Big Buy

If there's one thing you can count on from Wall Street, it's repetitious analysis of big tech news.

Take the Amazon.com Inc. (Nasdaq: AMZN) purchase of Whole Foods Market Inc. (Nasdaq: WFM) for $13.7 billion last week.

A steady, predictable stream of stories quoting analysts about the "death of retail" followed the announcement.

Don't get me wrong - that's a big, ongoing story. It's one I wrote about in the past, as recently as May 23.

What they missed is how this is a boon for technology: mobile commerce, Big Data, machine vision and learning, chips, sensors... and especially robots.

Robots already are all over Amazon's warehouses and are a big part of its success.

Now they'll be in Whole Foods' warehouses, checkout lines, and maybe even a part of making deliveries.

You could buy Amazon - and I recommend you do establish a position if you haven't yet - but that'll cost you.

You could buy a robotics stock, but that will only scratch the surface.

Or you could make this one move and get at least double the market's return...

Automation Is Coming

I was excited when I woke up to news of the Amazon-Whole Foods merger. However, I was focused on the logistics and tech angles that financial analysts evidently forgot.

While Amazon picks up the massive list of gourmet items and devoted shoppers at Whole Foods' 460 retail outlets, it also acquired access to all those stores' freezers and storage rooms.

With localized cold storage, Amazon can truly make good on its promise of same-day delivery of not just groceries but also many other goods.

Even better, most of these stores are close to wealthy ZIP codes. I see these folks as the most likely early adopters of "unmanned" deliveries.

Amazon is already pioneering drone-based deliveries. And small robotic delivery vehicles could be next.

Beyond those are the in-house robotics and automation plays. Under CEO Jeff Bezos, Amazon has pushed these two areas like few companies have.

Robotic handlers and sorters could be a huge boon to the grocery sector, by cutting costs and beefing up the notoriously thin margins. As such, the Amazon deal will be a great case study in the value of the robotics revolution. This is a fertile field to be sure.

Research firm Allied Market Research predicts the global robotics market will grow at an average compound rate of 10% through the end 2020, when the sector will have a value of $82.7 billion.

The firm notes that robots are finding use in a wide range of sectors. Auto assembly takes the top market share, accounting for about 39% of sales growth. Electronics follows with 20%.

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Robot Invasion

With so much going on in the global robotics field, tech investors ought to consider the Robo-Stox Global Robotics & Automation ETF (Nasdaq: ROBO).

Holding 91 stocks, the fund covers just about every conceivable robotics and factory automation angle. So, we're talking everything from 3D printing and chips to drones and massive industrial robots.

There's some fascinating tech in this ETF. Just take a look at some of its top holdings:

The road to wealth is paved by tech – and it starts with Michael Robinson's Strategic Tech Investor. Twice a week, Michael leverages his 30-plus years of experience in the tech industry to put you directly in touch with the research, analysis, stock picks, and strategies that can double, triple – even quadruple your money faster than any other sector on earth. Just click here to get started, and we'll deliver his Strategic Tech Investor straight to your inbox, absolutely free.
  • Cognex Corp. (Nasdaq: CGNX) is a world leader in machine vision. It also supplies software, vision sensors, and industrial ID readers used in manufacturing automation. These systems are used for guiding assembly robots and also for tracking, sorting, and identifying products. This is the kind of technology that Amazon will need. For its part, Cognex is already a key supplier to Apple Inc. (Nasdaq: AAPL) for its vision systems that can detect product defects, a key part of quality control. It also produces logistics barcode readers and tracking software.
  • IRobot Corp. (Nasdaq: IRBT) is all about automating the home. Founded in 1990, the firm was early to the U.S. robotics revolution. Today, it's the leader in consumer robots. Its best-known product, the Roomba vacuum cleaner, contains onboard navigation as well as vision for in-home landmarks for improved mapping. It also integrates to a smartphone app. The Braava is used for mopping floors, while the Mirra is an underwater robot used for cleaning pools. It's designed to climb walls as well as transit a flat surface. IRobot also runs a venture fund that invests in robotics, smart home, and automation startups.
  • Autodesk Inc. (Nasdaq: ADSK) pioneered complex software vital to making a wide range of products around the world. The field is known as CAD/CAM (computer-aided design/computer-aided modeling). The tech itself is complex, but the idea behind it all is very simple - use software to design the product and then to control the machines that make it. Whether it's a surgical tool, an artificial aorta, a fuel nozzle, or a bike helmet, Autodesk's CAD/CAM software plays a role in it all.

ROBO launched in late November 2013. To mark the occasion, Nasdaq officials used a robotic arm to ring the closing bell. Nice touch.

Priced at just $35, ROBO trades at a fraction of some of its notable portfolio holdings. And Wall Street is starting to wake up to the value that a balanced robotics play like ROBO represents.

So far this year, ROBO has gained 21.9%. That's more than double the S&P 500's 9.5% return during the same period.

But remember, this fund is really just getting started... so its best days are yet to come.

I believe this is an ETF that offers patient tech investors some excellent long-term potential - and would make a great foundational play for your portfolio.

Editor's Note: One of the fastest-growing tech investment segments is… cannabis? Yes, you read that right. A high-tech approach to cultivating this ancient plant – that's already legal to use in more than half of 50 states – is generating a multibillion-dollar investment opportunity for early investors. Click here to find out more, including how you can get your copy of Michael Robinson's Roadmap to Marijuana Millions. Packed with more than 30 great companies to buy, it's fast becoming "the weed investor's bible." Check it out

The post Nobody Is Talking About the Best Tech Play After Amazon's Big Buy appeared first on Strategic Tech Investor.

About the Author

Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...

  • He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
  • He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
  • As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.

This all means the entire world is constantly seeking Michael's insight.

In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.

Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.

And even with decades of experience, Michael believes there has never been a moment in time quite like this.

Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.

To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.

His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.

Read full bio